BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2635677)

  • 1. [Dihydropyridines are not the only antihypertensives. Calcium blockers in the therapy of elderly hypertensive patients].
    Fortschr Med Suppl; 1989; 71():1-18. PubMed ID: 2635677
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
    Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
    J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
    MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Also for problem cases; successful first line therapy].
    MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
    Christensen KL
    Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A
    Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
    MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blocker.
    Li CJ; Shi ZD
    Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
    [No Abstract]   [Full Text] [Related]  

  • 10. Some similarities and differences between verapamil and the dihydropyridines.
    Antonios TF; MacGregor GA
    J Hypertens Suppl; 1998 Jan; 16(1):S31-4. PubMed ID: 9534094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[Antihypertensive therapy and organ protection].
    Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
    Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of elderly hypertension with Ca channel blockers].
    Saito F; Kushiro T
    Clin Calcium; 2005 Oct; 15(10):1717-25. PubMed ID: 16199919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical advantages of lipophilic dihydropyridines.
    Mancia G; Omboni S; Zanchetti A
    Blood Press Suppl; 1998; 2():23-6. PubMed ID: 9850439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
    Meier P; Burnier M
    Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dihydropyridinic calcium channel blockers in the management of hypertension.
    Coca A; Mazón P; Aranda P; Redón J; Divisón JA; Martínez J; Calvo C; Galcerán JM; Barrios V; Roca-Cusachs I Coll A
    Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):91-105. PubMed ID: 23259449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
    Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK
    Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects].
    Borghi C
    Rev Med Suisse; 2006 May; 2(65):1266-7. PubMed ID: 16767882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.